Regenerative Medical Technology (RMTG) Operating Leases (2022 - 2026)

Regenerative Medical Technology has reported Operating Leases for 5 years, with the latest figure at $492425.0 in Q2 2026.

• On a quarterly basis, Operating Leases rose 80.07% year-over-year to $492425.0 in Q2 2026; TTM through Jun 2026 was $492425.0, a 80.07% increase from a year earlier, with the FY2025 full-year figure at $409110.0, up 93.24% from the prior year.
• Operating Leases was $492425.0 for Q2 2026 at Regenerative Medical Technology, down from $591731.0 in the prior quarter.
• The five-year high for Operating Leases was $591731.0 in Q1 2026, with the low at $1395.0 in Q4 2022.
• Average Operating Leases over 5 years is $208633.7, with a median of $125004.0 recorded in 2024.
• The sharpest annual moves came in 2024 and 2026: Operating Leases jumped 7700.88% in 2024, then soared 80.07% in 2026.
• Over 5 years, Operating Leases stood at $1395.0 in 2022, then jumped by 94.55% to $2714.0 in 2023, then surged by 7700.88% to $211716.0 in 2024, then soared by 93.24% to $409110.0 in 2025, then rose by 20.36% to $492425.0 in 2026.
• The last three Operating Leases figures came in at $492425.0 (Q2 2026), $591731.0 (Q1 2026), and $409110.0 (Q4 2025), per Business Quant data.